Compare JCSE & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JCSE | ADVB |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | Singapore | Hong Kong |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8M | 8.6M |
| IPO Year | 2022 | 2023 |
| Metric | JCSE | ADVB |
|---|---|---|
| Price | $1.48 | $4.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.3K | ★ 15.3K |
| Earning Date | 10-29-2026 | 10-13-2026 |
| Dividend Yield | ★ 29.93% | N/A |
| EPS Growth | N/A | ★ 3431.25 |
| EPS | N/A | ★ 5.33 |
| Revenue | N/A | ★ $127,637.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | $3.66 |
| 52 Week High | $2.50 | $113.80 |
| Indicator | JCSE | ADVB |
|---|---|---|
| Relative Strength Index (RSI) | 51.40 | 23.26 |
| Support Level | $1.32 | $3.86 |
| Resistance Level | $1.56 | $5.59 |
| Average True Range (ATR) | 0.05 | 0.48 |
| MACD | 0.01 | -0.15 |
| Stochastic Oscillator | 50.00 | 8.94 |
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company has two operating segments namely sale of cleaning systems and other equipment and provision of centralized dishware washing and general cleaning services. Geographically, the company derives a majority of its revenue from Singapore.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.